Abstract: The blood‒brain barrier (BBB) is a vital physiological structure that maintains the microenvironmental homeostasis in the central nervous system (CNS). Imbalances in its permeability play a key role in various neurological disorders, including stroke, neurodegenerative diseases, and brain tumors. The development of precise techniques for assessing BBB permeability is therefore paramount for elucidating the mechanisms of neurological diseases, overcoming drug development challenges, and achieving precise diagnosis and treatment of CNS disorders. This review systematically summarizes the latest advances in the assessment of BBB permeability. Regarding in vitro models, platforms have evolved from the traditional transwell system to microfluidic chips incorporating fluid shear forces and subsequently to highly biomimetic brain organoids, with continuous improvements in the ability to simulate the neurovascular unit (NVU) microenvironment. For in vivo assessment, we detail the principles and applications of imaging techniques, including dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), positron emission tomography (PET), near-infrared II (NIR-II) fluorescence imaging (FI), and two-photon microscopy (TPM), highlighting their complementary strengths in macroscopic quantification, molecular targeting, and microscopic dynamic observation. The integration of multi-modal technologies and precise quantitative assessment is a prominent trend. Future investigations will focus on artificial intelligence (AI)-driven personalized permeability assessment, the development of novel intelligent probes, and the dynamic real-time monitoring of the BBB, thereby providing powerful methodological support for neurological disease research.

血脑屏障通透性评估技术进展：从仿生模型到多模态成像

[1]AhlawatJ, BarrosoGG, AsilSM, et al., 2020. Nanocarriers as potential drug delivery candidates for overcoming the blood‒brain barrier: challenges and possibilities. ACS Omega, 5(22):12583-12595.

[2]AmbudkarSV, DeyS, HrycynaCA, et al., 1999. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol, 39:361-398.

[3]AndersonJM, van ItallieCM, 2009. Physiology and function of the tight junction. Cold Spring Harb Perspect Biol, 1:a002584.

[4]Appelt-MenzelA, CubukovaA, GüntherK, et al., 2017. Establishment of a human blood‒brain barrier co-culture model mimicking the neurovascular unit using induced pluri- and multipotent stem cells. Stem Cell Rep, 8(4):894-906.

[5]Badiola-MateosM, di GiuseppeD, PaoliR, et al., 2021. A novel multi-frequency trans-endothelial electrical resistance (MTEER) sensor array to monitor blood‒brain barrier integrity. Sens Actuators B Chem, 334:129599.

[6]BagchiS, ChhibberT, LahootiB, et al., 2019. In-vitro blood‒brain barrier models for drug screening and permeation studies: an overview. Drug Des Devel Ther, 13:3591-3605.

[7]BalzerV, PocP, PurisE, et al., 2022. Re-evaluation of the hCMEC/D3 based in vitro BBB model for ABC transporter studies. Eur J Pharm Biopharm, 173:12-21.

[8]BanerjeeJ, ShiYJ, AzevedoHS, 2016. In vitro blood‒brain barrier models for drug research: state-of-the-art and new perspectives on reconstituting these models on artificial basement membrane platforms. Drug Discov Today, 21(9):1367-1386.

[9]BanksWA, 2016. From blood‒brain barrier to blood‒brain interface: new opportunities for CNS drug delivery. Nat Rev Drug Discov, 15:275-292.

[10]BayirE, CeltikogluMM, SendemirA, 2019. The use of bacterial cellulose as a basement membrane improves the plausibility of the static in vitro blood‒brain barrier model. Int J Biol Macromol, 126:1002-1013.

[11]BellRD, WinklerEA, SagareAP, et al., 2010. Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron, 68(3):409-427.

[12]BensonK, CramerS, GallaHJ, 2013. Impedance-based cell monitoring: barrier properties and beyond. Fluids Barriers CNS, 10:5.

[13]BergmannS, LawlerSE, QuY, et al., 2018. Blood‒brain-barrier organoids for investigating the permeability of CNS therapeutics. Nat Protoc, 13(12):2827-2843. https:/doi.org/10.1038/s41596-018-0066-x

[14]BhattacharyaA, KaushikDK, LozinskiBM, et al., 2020. Beyond barrier functions: roles of pericytes in homeostasis and regulation of neuroinflammation. J Neurosci Res, 98(12):2390-2405.

[15]CaoJ, ZhuBL, ZhengKF, et al., 2020. Recent progress in NIR-II contrast agent for biological imaging. Front Bioeng Biotechnol, 7:487.

[16]CaoPY, HeY, CuiMY, et al., 2024. Group graph: a molecular graph representation with enhanced performance, efficiency and interpretability. J Cheminform, 16:133.

[17]CeccarelliMC, LefevreMC, MarinoA, et al., 2024. Real-time monitoring of a 3D blood‒brain barrier model maturation and integrity with a sensorized microfluidic device. Lab Chip, 24(22):5085-5100.

[18]CecchelliR, BerezowskiV, LundquistS, et al., 2007. Modelling of the blood‒brain barrier in drug discovery and development. Nat Rev Drug Discov, 6:650-661.

[19]ChenHJ, TongX, LangLX, et al., 2017. Quantification of tumor vascular permeability and blood volume by positron emission tomography. Theranostics, 7(9):2363-2376.

[20]ChenHY, MirgS, GaddaleP, et al., 2024. Multiparametric brain hemodynamics imaging using a combined ultrafast ultrasound and photoacoustic system. Adv Sci, 11(31):2401467.

[21]ChenXY, XuJ, GuoSY, et al., 2024. Blood‒brain barrier permeability by CT perfusion predicts parenchymal hematoma after recanalization with thrombectomy. J Neuroimaging, 34(2):241-248.

[22]ChungB, KimJ, NamJ, et al., 2020. Evaluation of cell-penetrating peptides using microfluidic in vitro 3D brain endothelial barrier. Macromol Biosci, 20(6):1900425.

[23]ChungKJ, AbdelhafezYG, SpencerBA, et al., 2025. Quantitative PET imaging and modeling of molecular blood‒brain barrier permeability. Nat Commun, 16:3076.

[24]ClarkDE, 2003. In silico prediction of blood‒brain barrier permeation. Drug Discov Today, 8(20):927-933.

[25]CornfordEM, HymanS, 1999. Blood‒brain barrier permeability to small and large molecules. Adv Drug Deliv Rev, 36(2-3):145-163.

[26]CuculloL, CouraudPO, WekslerB, et al., 2008. Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies. J Cereb Blood Flow Metab, 28(2):312-328.

[27]CuculloL, MarchiN, HossainM, et al., 2011. A dynamic in vitro BBB model for the study of immune cell trafficking into the central nervous system. J Cereb Blood Flow Metab, 31(2):767-777.

[28]DaiJF, WeiWJ, YanCX, et al., 2025. Multiplex imaging of amyloid-β plaques dynamics in living brains with quinoline-malononitrile-based probes. Nat Biomed Eng, 9:1632-1644.

[29]DanielsBP, Cruz-OrengoL, PasiekaTJ, et al., 2013. Immortalized human cerebral microvascular endothelial cells maintain the properties of primary cells in an in vitro model of immune migration across the blood brain barrier. J Neurosci Methods, 212(1):173-179.

[30]DaoL, YouZ, LuL, et al., 2024. Modeling blood‒brain barrier formation and cerebral cavernous malformations in human PSC-derived organoids. Cell Stem Cell, 31(6):818-833.e11.

[31]de VivoDC, TrifilettiRR, JacobsonRI, et al., 1991. Defective glucose transport across the blood‒brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med, 325(10):703-709.

[32]DeliMA, ÁbrahámCS, KataokaY, et al., 2005. Permeability studies on in vitro blood‒brain barrier models: physiology, pathology, and pharmacology. Cell Mol Neurobiol, 25:59-127.

[33]DenkW, StricklerJH, WebbWW, 1990. Two-photon laser scanning fluorescence microscopy. Science, 248:73-76.

[34]DeyV, NingX, 2024. Enhancing molecular property prediction with auxiliary learning and task-specific adaptation. J Cheminform, 16:85.

[35]DohguS, TakataF, YamauchiA, et al., 2005. Brain pericytes contribute to the induction and up-regulation of blood‒brain barrier functions through transforming growth factor-β production. Brain Res, 1038(2):208-215.

[36]DongXW, 2018. Current strategies for brain drug delivery. Theranostics, 8(6):1481-1493.

[37]DouvilleNJ, TungYC, LiR, et al., 2010. Fabrication of two-layered channel system with embedded electrodes to measure resistance across epithelial and endothelial barriers. Anal Chem, 82(6):2505-2511.

[38]Fernández‐SearaMA, WangZ, WangJJ, et al., 2005. Continuous arterial spin labeling perfusion measurements using single shot 3D GRASE at 3 T. Magn Reson Med, 54(5):1241-1247.

[39]FrankeH, GallaHJ, BeuckmannCT, 1999. An improved low-permeability in vitro-model of the blood‒brain barrier: transport studies on retinoids, sucrose, haloperidol, caffeine and mannitol. Brain Res, 818(1):65-71.

[40]GrantN, Machado ReyesD, YangZF, et al., 2025. Blood brain barrier permeability prediction with artificial intelligence and machine learning: a meta-review and future directions. Discov Artif Intell, 5:254.

[41]GrkovskiR, AcuL, AhmadliU, et al., 2023a. A novel dual-energy CT method for detection and differentiation of intracerebral hemorrhage from contrast extravasation in stroke patients after endovascular thrombectomy: feasibility and first results. Clin Neuroradiol, 33:171-177.

[42]GrkovskiR, AcuL, AhmadliU, et al., 2023b. Dual-energy computed tomography in stroke imaging: value of a new image acquisition technique for ischemia detection after mechanical thrombectomy. Clin Neuroradiol, 33:747-754.

[43]HajalC, OffedduGS, ShinY, et al., 2022. Engineered human blood‒brain barrier microfluidic model for vascular permeability analyses. Nat Protoc, 17:95-128.

[44]HarilalS, JoseJ, ParambiDGT, et al., 2020. Revisiting the blood‒brain barrier: a hard nut to crack in the transportation of drug molecules. Brain Res Bull, 160:121-140.

[45]HeQG, LiuJ, LiangJ, et al., 2018. Towards improvements for penetrating the blood-brain barrier—recent progress from a material and pharmaceutical perspective. Cells, 7(4):24.

[46]HeyeAK, CullingRD, HernándezMDCV, et al., 2014. Assessment of blood‒brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review. Neuroimage Clin, 6:262-274.

[47]HongGS, LeeJC, RobinsonJT, et al., 2012. Multifunctional in vivo vascular imaging using near-infrared II fluorescence. Nat Med, 18:1841-1846.

[48]HongGS, AntarisAL, DaiHJ, 2017. Near-infrared fluorophores for biomedical imaging. Nat Biomed Eng, 1:0010.

[49]HuiJ, LiR, PhillipsEH, et al., 2016. Bond-selective photoacoustic imaging by converting molecular vibration into acoustic waves. Photoacoustics, 4:11-21.

[50]HurstRD, FritzIB, 1996. Properties of an immortalised vascular endothelial/glioma cell co-culture model of the blood‒brain barrier. J Cell Physiol, 167:81-88.

[51]IliffJJ, WangMH, LiaoYH, et al., 2012. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci Transl Med, 4:147ra111.

[52]ItoR, UmeharaK, SuzukiS, et al., 2019. A human immortalized cell-based blood‒brain barrier triculture model: development and characterization as a promising tool for drug‒brain permeability studies. Mol Pharm, 16(11):4461-4471.

[53]JacksonI, LuoA, WebbE, et al., 2021. A new in silico approach to revolutionize CNS PET tracer design and enhance translational success. Nucl Med Biol, 96-97:S24-S25.

[54]JanigroD, LeamanSM, StannessKA, 1999. Dynamic in vitro modeling of the blood‒brain barrier: a novel tool for studies of drug delivery to the brain. Pharm Sci Technol Today, 2:7-12.

[55]JiangDJ, WuZX, HsiehCY, et al., 2021. Could graph neural networks learn better molecular representation for drug discovery? A comparison study of descriptor-based and graph-based models. J Cheminform, 13:12.

[56]JiangLL, LiS, ZhengJS, et al., 2019. Recent progress in microfluidic models of the blood‒brain barrier. Micromachines, 10(6):375.

[57]JohnsonTRC, KraußB, SedlmairM, et al., 2007. Material differentiation by dual energy CT: initial experience. Eur Radiol, 17(6):1510-1517.

[58]JulianoRL, LingV, 1976. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta (BBA)-Biomembr, 455:152-162.

[59]KadryH, NooraniB, CuculloL, 2020. A blood‒brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS, 17:69.

[60]KislerK, NelsonAR, RegeSV, et al., 2017. Pericyte degeneration leads to neurovascular uncoupling and limits oxygen supply to brain. Nat Neurosci, 20:406-416.

[61]KrolS, MacrezR, DocagneF, et al., 2013. Therapeutic benefits from nanoparticles: the potential significance of nanoscience in diseases with compromise to the blood brain barrier. Chem Rev, 113(3):1877-1903.

[62]LeeS, KangBM, KimJH, et al., 2018. Real-time in vivo two-photon imaging study reveals decreased cerebro-vascular volume and increased blood‒brain barrier permeability in chronically stressed mice. Sci Rep, 8:13064.

[63]LiJ, WangTT, ZhangX, et al., 2025. Chalcogenapyrylium-engineered D-π-A probe for enhanced optoacoustic imaging of amyloid-β plaques. Sens Actuators B Chem, 442:138086.

[64]LiWJ, ZhaXC, ZhangXY, et al., 2025. Enhanced positron emission tomography imaging of β-amyloid through focused ultrasound-mediated gallium-68 radiotracer delivery across the blood‒brain barrier. ACS Chem Neurosci, 16(15):3070-3081.

[65]LiXH, FourchesD, 2020. Inductive transfer learning for molecular activity prediction: Next-Gen QSAR Models with MolPMoFiT. J Cheminform, 12:27.

[66]LinL, WangLV, 2022. The emerging role of photoacoustic imaging in clinical oncology. Nat Rev Clin Oncol, 19:365-384.

[67]LinZX, LiY, SuP, et al., 2018. Non-contrast MR imaging of blood‒brain barrier permeability to water. Magn Reson Med, 80(4):1507-1520.

[68]LiuJJ, WangT, DongJ, et al., 2025. The blood-brain barriers: novel nanocarriers for central nervous system diseases. J Nanobiotechnol, 23:146.

[69]LiuLL, ZhangL, FengHW, et al., 2021. Prediction of the blood‒brain barrier (BBB) permeability of chemicals based on machine-learning and ensemble methods. Chem Res Toxicol, 34(6):1456-1467.

[70]LiuPY, UhJ, LuHZ, 2011. Determination of spin compartment in arterial spin labeling MRI. Magn Reson Med, 65(1):120-127.

[71]LiuXG, DuanYK, LiuB, 2021. Nanoparticles as contrast agents for photoacoustic brain imaging. Aggregate, 2:4-19.

[72]LoganS, ArzuaT, CanfieldSG, et al., 2019. Studying human neurological disorders using induced pluripotent stem cells: from 2D monolayer to 3D organoid and blood brain barrier models. Compr Physiol, 9(2):565-611.

[73]LuC, MengC, LiYY, et al., 2024. A probe for NIR-II imaging and multimodal analysis of early Alzheimer’s disease by targeting CTGF. Nat Commun, 15:5000.

[74]LuissintAC, ArtusC, GlacialF, et al., 2012. Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation. Fluids Barriers CNS, 9:23.

[75]MalikM, SteeleSA, MitraD, et al., 2025. Trans-epithelial/endothelial electrical resistance (TEER): current state of integrated TEER measurements in organ-on-a-chip devices. Curr Opin Biomed Eng, 34:100588.

[76]MalinovaTS, HuveneersS, 2018. Sensing of cytoskeletal forces by asymmetric adherens junctions. Trends Cell Biol, 28(4):328-341.

[77]Mantecón-OriaM, DibanN, BercianoMT, et al., 2020. Hollow fiber membranes of PCL and PCL/graphene as scaffolds with potential to develop in vitro blood‒brain barrier models. Membranes, 10(8):161.

[78]Mantecón-OriaM, TapiaO, LafargaM, et al., 2022a. Influence of the properties of different graphene-based nanomaterials dispersed in polycaprolactone membranes on astrocytic differentiation. Sci Rep, 12:13408.

[79]Mantecón-OriaM, RiveroMJ, DibanN, et al., 2022b. On the quest of reliable 3D dynamic in vitro blood‒brain barrier models using polymer hollow fiber membranes: pitfalls, progress, and future perspectives. Front Bioeng Biotechnol, 10:1056162.

[80]Mantecón-OriaM, RiveroMJ, LöscherW, et al., 2025. Breaking optical barriers: transparent polymeric hollow fibers for biomedical applications. View, 6(6):20250076.

[81]MármolI, Abizanda-CampoS, AyusoJM, et al., 2023. Towards novel biomimetic in vitro models of the blood‒brain barrier for drug permeability evaluation. Bioengineering, 10(5):572.

[82]MilesKA, GriffithsMR, 2003. Perfusion CT: a worthwhile enhancement? Br J Radiol, 76:220-231.

[83]MouchtourisN, AilesI, GoochR, et al., 2024. Quantifying blood‒brain barrier permeability in patients with ischemic stroke using non-contrast MRI. Magn Reson Imaging, 109:165-172.

[84]MuruganandamA, HerxLM, MonetteR, et al., 1997. Development of immortalized human cerebromicrovascular endothelial cell line as an in vitro model of the human blood‒brain barrier. FASEB J, 11(13):1187-1197.

[85]NaikP, CuculloL, 2012. In vitro blood‒brain barrier models: current and perspective technologies. J Pharm Sci, 101(4):1337-1354.

[86]NakagawaS, DeliMA, KawaguchiH, et al., 2009. A new blood‒brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Neurochem Int, 54(3-4):253-263.

[87]NationDA, SweeneyMD, MontagneA, et al., 2019. Blood‒brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med, 25:270-276.

[88]NazariH, ShresthaJ, NaeiVY, et al., 2023. Advances in TEER measurements of biological barriers in microphysiological systems. Biosens Bioelectron, 234:115355.

[89]NeuhausW, LauerR, OelzantS, et al., 2006. A novel flow based hollow-fiber blood‒brain barrier in vitro model with immortalised cell line PBMEC/C1-2. J Biotechnol, 125(1):127-141.

[90]NogueiraDES, CabralJMS, RodriguesCAV, 2021. Single-use bioreactors for human pluripotent and adult stem cells: towards regenerative medicine applications. Bioengineering, 8(5):68.

[91]NzouG, WicksRT, WicksEE, et al., 2018. Human cortex spheroid with a functional blood brain barrier for high-throughput neurotoxicity screening and disease modeling. Sci Rep, 8:7413.

[92]OddoA, PengB, TongZQ, et al., 2019. Advances in microfluidic blood‒brain barrier (BBB) models. Trends Biotechnol, 37(12):1295-1314.

[93]PanditR, ChenLY, GötzJ, 2020. The blood‒brain barrier: physiology and strategies for drug delivery. Adv Drug Deliv Rev, 165-166:1-14.

[94]PardridgeWM, 2005. The blood‒brain barrier: bottleneck in brain drug development. NeuroRx, 2:3-14.

[95]ParkesLM, ToftsPS, 2002. Improved accuracy of human cerebral blood perfusion measurements using arterial spin labeling: accounting for capillary water permeability. Magn Reson Med, 48(1):27-41.

[96]PoonCT, ShahK, LinC, et al., 2018. Time course of focused ultrasound effects on β-amyloid plaque pathology in the TgCRND8 mouse model of Alzheimer’s disease. Sci Rep, 8:14061.

[97]QinW, LiHH, ChenJL, et al., 2025. Amphiphilic hemicyanine molecular probes crossing the blood-brain barrier for intracranial optical imaging of glioblastoma. Sci Adv, 11:eadq5816.

[98]RajaR, RosenbergGA, CaprihanA, 2018. MRI measurements of blood‒brain barrier function in dementia: a review of recent studies. Neuropharmacology, 134:259-271.

[99]RollinsZA, ChengAC, MetwallyE, 2024. MolPROP: molecular property prediction with multimodal language and graph fusion. J Cheminform, 16:56.

[100]RubinLL, HallDE, PorterS, et al., 1991. A cell culture model of the blood‒brain barrier. J Cell Biol, 115(6):1725-1735.

[101]SaxenaD, SharmaA, SiddiquiMH, et al., 2019. Blood brain barrier permeability prediction using machine learning techniques: an update. Curr Pharm Biotechnol, 20(14):1163-1171.

[102]SchurhoffN, ToborekM, 2023. Circadian rhythms in the blood‒brain barrier: impact on neurological disorders and stress responses. Mol Brain, 16:5.

[103]SegarraM, AburtoMR, Acker-PalmerA, 2021. Blood‒brain barrier dynamics to maintain brain homeostasis. Trends Neurosci, 44(5):393-405.

[104]ShakerB, YuMS, SongJS, et al., 2021. LightBBB: computational prediction model of blood‒brain-barrier penetration based on LightGBM. Bioinformatics, 37(8):1135-1139.

[105]ShangBL, WangT, ZhaoSL, et al., 2024. Higher blood‒brain barrier permeability in patients with major depressive disorder identified by DCE-MRI imaging. Psychiatry Res Neuroimaging, 337:111761.

[106]Shumer-ElbazM, Ad-ElN, ChulanovaY, et al., 2025. Low-frequency ultrasound-mediated blood‒brain barrier opening enables non-invasive lipid nanoparticle RNA delivery to glioblastoma. J Control Release, 385:114018.

[107]SiegelMJ, KazaRK, BolusDN, et al., 2016. White paper of the Society of Computed Body Tomography and magnetic resonance on dual-energy CT, Part 1: technology and terminology. J Comput Assist Tomogr, 40(6):841-845.

[108]SimonneauC, DuschmaléM, GavrilovA, et al., 2021. Investigating receptor-mediated antibody transcytosis using blood‒brain barrier organoid arrays. Fluids Barriers CNS, 18:43.

[109]SivandzadeF, CuculloL, 2018. In-vitro blood‒brain barrier modeling: a review of modern and fast-advancing technologies. J Cereb Blood Flow Metab, 38(10):1667-1681.

[110]SonninenTM, PeltonenS, KälväläS, et al., 2025. From inserts to chips: microfluidic culture and 3D astrocyte co-culture drive functional and transcriptomic changes in hiPSC-derived endothelial cells. Fluids Barriers CNS, 22:58.

[111]SrinivasanB, KolliAR, EschMB, et al., 2015. TEER measurement techniques for in vitro barrier model systems. J Lab Autom, 20(2):107-126.

[112]St. Lawrence KS, Frank JA, McLaughlin AC, 2000. Effect of restricted water exchange on cerebral blood flow values calculated with arterial spin tagging: a theoretical investigation. Magn Reson Med, 44(3):440-449.

[113]St. Lawrence KS, Owen D, Wang DJJ, 2012. A two-stage approach for measuring vascular water exchange and arterial transit time by diffusion-weighted perfusion MRI. Magn Reson Med, 67(5):1275-1284.

[114]StamatovicSM, JohnsonAM, KeepRF, et al., 2016. Junctional proteins of the blood‒brain barrier: new insights into function and dysfunction. Tissue Barriers, 4(1):e1154641.

[115]StannessKA, WestrumLE, FornaciariE, et al., 1997. Morphological and functional characterization of an in vitro blood‒brain barrier model. Brain Res, 771(2):329-342.

[116]SunJD, SongS, 2024. Advances in modeling permeability and selectivity of the blood‒brain barrier using microfluidics. Microfluid Nanofluidics, 28(7):44.

[117]TevosyanA, KhondkaryanL, KhachatrianH, et al., 2022. Improving VAE based molecular representations for compound property prediction. J Cheminform, 14:69.

[118]ToyoharaJ, 2016. Importance of P-gp PET imaging in pharmacology. Curr Pharm Des, 22(38):5830-5836.

[119]TurowskiP, KennyBA, 2015. The blood‒brain barrier and methamphetamine: open sesame? Front Neurosci, 9:156.

[120]van de HaarHJ, BurgmansS, JansenJFA, et al., 2016. Blood‒brain barrier leakage in patients with early Alzheimer disease. Radiology, 281(2):527-535.

[121]van der HelmMW, OdijkM, FrimatJP, et al., 2016. Direct quantification of transendothelial electrical resistance in organs-on-chips. Biosens Bioelectron, 85:924-929.

[122]VerstappenD, de JongJJA, VoorterPHM, et al., 2025. DCE-MRI reveals spatial pattern in heterogeneous blood‒brain barrier leakage within white matter in cerebral small vessel disease. J Cereb Blood Flow Metab, 45(11):2104-2114.

[123]VorbrodtAW, DobrogowskaDH, 2003. Molecular anatomy of intercellular junctions in brain endothelial and epithelial barriers: electron microscopist’s view. Brain Res Rev, 42(3):221-242.

[124]WangD, ChenFL, HanZL, et al., 2021. Relationship between amyloid-β deposition and blood‒brain barrier dysfunction in Alzheimer’s disease. Front Cell Neurosci, 15:695479.

[125]WangGX, ZhouYY, YuCH, et al., 2024. Intravital photoacoustic brain stimulation with high-precision. J Biomed Opt, 29(S1):S11520.

[126]WangJJ, Fernández-SearaMA, WangSM, et al., 2007. When perfusion meets diffusion: in vivo measurement of water permeability in human brain. J Cereb Blood Flow Metab, 27(4):839-849.

[127]WangSC, ShiH, WangLS, et al., 2022. Photostable small-molecule NIR-II fluorescent scaffolds that cross the blood‒brain barrier for noninvasive brain imaging. J Am Chem Soc, 144(51):23668-23676.

[128]WangX, LiP, DingQ, et al., 2019. Observation of acetylcholinesterase in stress-induced depression phenotypes by two-photon fluorescence imaging in the mouse brain. J Am Chem Soc, 141(5):2061-2068.

[129]WangXB, HouY, AiXP, et al., 2020. Potential applications of microfluidics based blood brain barrier (BBB)-on-chips for in vitro drug development. Biomed Pharmacother, 132:110822.

[130]WekslerB, RomeroIA, CouraudPO, 2013. The hCMEC/D3 cell line as a model of the human blood brain barrier. Fluids Barriers CNS, 10:16.

[131]WenNF, LiuGQ, ZhangJ, et al., 2022. A fingerprints based molecular property prediction method using the BERT model. J Cheminform, 14:71.

[132]WeversNR, KasiDG, GrayT, et al., 2018. A perfused human blood‒brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport. Fluids Barriers CNS, 15:23.

[133]WinklhoferS, de MartiniIV, NernC, et al., 2017. Dual-energy computed tomography in stroke imaging: technical and clinical considerations of virtual noncontrast images for detection of the hyperdense artery sign. J Comput Assist Tomogr, 41(6):843-848.

[134]WithnallM, LindelöfE, EngkvistO, et al., 2020. Building attention and edge message passing neural networks for bioactivity and physical-chemical property prediction. J Cheminf, 12:1.

[135]WuD, ChenQ, ChenXJ, et al., 2023. The blood‒brain barrier: structure, regulation and drug delivery. Signal Transduct Target Ther, 8:217.

[136]XiongCH, YuZY, YinY, et al., 2025. Longitudinal changes of blood‒brain barrier and transcytolemmal water exchange permeability in Alzheimer’s disease mice: a non-contrast MRI study. Neuroimage, 310:121141.

[137]XuHL, LiR, DuanYX, et al., 2017. Quantitative assessment on blood‒brain barrier permeability of acute spontaneous intracerebral hemorrhage in basal ganglia: a CT perfusion study. Neuroradiology, 59(7):677-684.

[138]YangG, PanF, ParkhurstCN, et al., 2010. Thinned-skull cranial window technique for long-term imaging of the cortex in live mice. Nat Protoc, 5:201-208.

[139]YangJY, ShinDS, JeongM, et al., 2024. Evaluation of drug blood‒brain-barrier permeability using a microfluidic chip. Pharmaceutics, 16(5):574.

[140]YangXY, WangQZ, CaoEH, 2020. Structure of the human cation-chloride cotransporter NKCC1 determined by single-particle electron cryo-microscopy. Nat Commun, 11:1016.

[141]YuanYX, ZhengF, ZhanCG, 2018. Improved prediction of blood‒brain barrier permeability through machine learning with combined use of molecular property-based descriptors and fingerprints. AAPS J, 20(3):54.

[142]ZhangCE, WongSM, UiterwijkR, et al., 2019. Blood‒brain barrier leakage in relation to white matter hyperintensity volume and cognition in small vessel disease and normal aging. Brain Imaging Behav, 13(2):389-395.

[143]ZhangHT, KangDH, PiantinoM, et al., 2023. Rapid quantification of microvessels of three-dimensional blood‒brain barrier model using optical coherence tomography and deep learning algorithm. Biosensors, 13(8):818.

[144]ZhangSS, GongP, ZhangJS, et al., 2020. Specific frequency electroacupuncture stimulation transiently enhances the permeability of the blood‒brain barrier and induces tight junction changes. Front Neurosci, 14:582324.

[145]ZhaoZ, NelsonAR, BetsholtzC, et al., 2015. Establishment and dysfunction of the blood‒brain barrier. Cell, 163(5):1064-1078.

[146]ZhengYY, ChenXJ, WangY, et al., 2024. Phenolic-enabled nanotechnology: a new strategy for central nervous system disease therapy. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 25(10):890-913.

Similar articles